Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stereoselective Covalent Adduct Formation of Acyl Glucuronide Metabolite of Nonsteroidal Anti-Inflammatory Drugs with UDP-Glucuronosyltransferase. | Int J Mol Sci | 2022 | 35563116 | PubTator, text mining | PubMed |
| Hydromorphone Prescription for Pain in Children-What Place in Clinical Practice? | Front Pediatr | 2022 | 35547539 | PubTator, text mining | PubMed |
| Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives. | Acta Pharm Sin B | 2022 | 35530147 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis. | Clin Pharmacol Ther | 2022 | 35510337 | PubTator, text mining | PubMed |
| Development and application of a pediatric mechanistic kidney model. | CPT Pharmacometrics Syst Pharmacol | 2022 | 35506351 | PubTator, text mining | PubMed |
| Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects. | Clin Drug Investig | 2022 | 35501592 | PubTator, text mining | PubMed |
| Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021. | Front Pharmacol | 2022 | 35496282 | PubTator, text mining | PubMed |
| Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital. | Front Pharmacol | 2022 | 35496268 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients. | Pharmaceutics | 2022 | 35456645 | PubTator, text mining | PubMed |
| Toxicokinetics of β-Amanitin in Mice and In Vitro Drug-Drug Interaction Potential. | Pharmaceutics | 2022 | 35456608 | PubTator, text mining | PubMed |
| Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects. | Pharmaceuticals (Basel) | 2022 | 35455393 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Progress, Challenges, and Prospects of Research on the Effect of Gene Polymorphisms on Adverse Reactions to Opioids. | Pain Ther | 2022 | 35429333 | PubTator, text mining | PubMed |
| Prediction of metabolizing enzyme-mediated clinical drug interactions using in vitro information. | Transl Clin Pharmacol | 2022 | 35419310 | PubTator, text mining | PubMed |
| A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease. | Br J Pain | 2022 | 35419195 | PubTator, text mining | PubMed |
| Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art. | Front Cardiovasc Med | 2022 | 35402528 | PubTator, text mining | PubMed |
| Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC). | Drug Metab Dispos | 2022 | 35370140 | PubTator, text mining | PubMed |
| Short Tandem Repeat Variation in the CNR1 Gene Associated With Analgesic Requirements of Opioids in Postoperative Pain Management. | Front Genet | 2022 | 35360861 | PubTator, text mining | PubMed |
| Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. | Front Pain Res (Lausanne) | 2022 | 35360655 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid Tumors. | J Clin Pharmacol | 2022 | 35358345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=22